ArticleFrontiers in endocrinology2025

Effectiveness of PCSK9 inhibitors versus statins in type 2 diabetes and dyslipidemia: a propensity-matched study.

Jheng-Yan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.